Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Male Hypogonadism Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Testosterone Replacement Therapy
1.2.3 Gonadotropin-Releasing Hormones Therapy
1.3 Market by Application
1.3.1 Global Male Hypogonadism Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Kallmann Syndrome
1.3.3 Klinefelters Syndrome
1.3.4 Pituitary Disorders
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Male Hypogonadism Market Perspective (2018-2033)
2.2 Male Hypogonadism Growth Trends by Region
2.2.1 Global Male Hypogonadism Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Male Hypogonadism Historic Market Size by Region (2018-2023)
2.2.3 Male Hypogonadism Forecasted Market Size by Region (2024-2033)
2.3 Male Hypogonadism Market Dynamics
2.3.1 Male Hypogonadism Industry Trends
2.3.2 Male Hypogonadism Market Drivers
2.3.3 Male Hypogonadism Market Challenges
2.3.4 Male Hypogonadism Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Male Hypogonadism Players by Revenue
3.1.1 Global Top Male Hypogonadism Players by Revenue (2018-2023)
3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2018-2023)
3.2 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Male Hypogonadism Revenue
3.4 Global Male Hypogonadism Market Concentration Ratio
3.4.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2022
3.5 Male Hypogonadism Key Players Head office and Area Served
3.6 Key Players Male Hypogonadism Product Solution and Service
3.7 Date of Enter into Male Hypogonadism Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Male Hypogonadism Breakdown Data by Type
4.1 Global Male Hypogonadism Historic Market Size by Type (2018-2023)
4.2 Global Male Hypogonadism Forecasted Market Size by Type (2024-2033)
5 Male Hypogonadism Breakdown Data by Application
5.1 Global Male Hypogonadism Historic Market Size by Application (2018-2023)
5.2 Global Male Hypogonadism Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Male Hypogonadism Market Size (2018-2033)
6.2 North America Male Hypogonadism Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Male Hypogonadism Market Size by Country (2018-2023)
6.4 North America Male Hypogonadism Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Male Hypogonadism Market Size (2018-2033)
7.2 Europe Male Hypogonadism Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Male Hypogonadism Market Size by Country (2018-2023)
7.4 Europe Male Hypogonadism Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Male Hypogonadism Market Size (2018-2033)
8.2 Asia-Pacific Male Hypogonadism Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Male Hypogonadism Market Size by Region (2018-2023)
8.4 Asia-Pacific Male Hypogonadism Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Male Hypogonadism Market Size (2018-2033)
9.2 Latin America Male Hypogonadism Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Male Hypogonadism Market Size by Country (2018-2023)
9.4 Latin America Male Hypogonadism Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Male Hypogonadism Market Size (2018-2033)
10.2 Middle East & Africa Male Hypogonadism Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Male Hypogonadism Market Size by Country (2018-2023)
10.4 Middle East & Africa Male Hypogonadism Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astrazeneca Plc.
11.1.1 Astrazeneca Plc. Company Detail
11.1.2 Astrazeneca Plc. Business Overview
11.1.3 Astrazeneca Plc. Male Hypogonadism Introduction
11.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2018-2023)
11.1.5 Astrazeneca Plc. Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Company Detail
11.2.2 Merck & Co. Inc. Business Overview
11.2.3 Merck & Co. Inc. Male Hypogonadism Introduction
11.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2018-2023)
11.2.5 Merck & Co. Inc. Recent Development
11.3 Laboratories Genevrier
11.3.1 Laboratories Genevrier Company Detail
11.3.2 Laboratories Genevrier Business Overview
11.3.3 Laboratories Genevrier Male Hypogonadism Introduction
11.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2018-2023)
11.3.5 Laboratories Genevrier Recent Development
11.4 Allergan Plc.
11.4.1 Allergan Plc. Company Detail
11.4.2 Allergan Plc. Business Overview
11.4.3 Allergan Plc. Male Hypogonadism Introduction
11.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2018-2023)
11.4.5 Allergan Plc. Recent Development
11.5 Endo International Plc.
11.5.1 Endo International Plc. Company Detail
11.5.2 Endo International Plc. Business Overview
11.5.3 Endo International Plc. Male Hypogonadism Introduction
11.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2018-2023)
11.5.5 Endo International Plc. Recent Development
11.6 Ferring
11.6.1 Ferring Company Detail
11.6.2 Ferring Business Overview
11.6.3 Ferring Male Hypogonadism Introduction
11.6.4 Ferring Revenue in Male Hypogonadism Business (2018-2023)
11.6.5 Ferring Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Detail
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Male Hypogonadism Introduction
11.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2018-2023)
11.7.5 AbbVie Inc. Recent Development
11.8 Eli Lilly and Company Ltd.
11.8.1 Eli Lilly and Company Ltd. Company Detail
11.8.2 Eli Lilly and Company Ltd. Business Overview
11.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction
11.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2018-2023)
11.8.5 Eli Lilly and Company Ltd. Recent Development
11.9 Finox Biotech
11.9.1 Finox Biotech Company Detail
11.9.2 Finox Biotech Business Overview
11.9.3 Finox Biotech Male Hypogonadism Introduction
11.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2018-2023)
11.9.5 Finox Biotech Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Detail
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Male Hypogonadism Introduction
11.11.4 Bayer AG Revenue in Male Hypogonadism Business (2018-2023)
11.11.5 Bayer AG Recent Development
11.12 IBSA Institut Biochimque
11.12.1 IBSA Institut Biochimque Company Detail
11.12.2 IBSA Institut Biochimque Business Overview
11.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction
11.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2018-2023)
11.12.5 IBSA Institut Biochimque Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Testosterone Replacement Therapy
Table 3. Key Players of Gonadotropin-Releasing Hormones Therapy
Table 4. Global Male Hypogonadism Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Male Hypogonadism Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Male Hypogonadism Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Male Hypogonadism Market Share by Region (2018-2023)
Table 8. Global Male Hypogonadism Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Male Hypogonadism Market Share by Region (2024-2033)
Table 10. Male Hypogonadism Market Trends
Table 11. Male Hypogonadism Market Drivers
Table 12. Male Hypogonadism Market Challenges
Table 13. Male Hypogonadism Market Restraints
Table 14. Global Male Hypogonadism Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Male Hypogonadism Market Share by Players (2018-2023)
Table 16. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2022)
Table 17. Ranking of Global Top Male Hypogonadism Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Male Hypogonadism Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Male Hypogonadism Product Solution and Service
Table 21. Date of Enter into Male Hypogonadism Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Male Hypogonadism Revenue Market Share by Type (2018-2023)
Table 25. Global Male Hypogonadism Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Male Hypogonadism Revenue Market Share by Type (2024-2033)
Table 27. Global Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Male Hypogonadism Revenue Market Share by Application (2018-2023)
Table 29. Global Male Hypogonadism Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Male Hypogonadism Revenue Market Share by Application (2024-2033)
Table 31. North America Male Hypogonadism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Male Hypogonadism Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Male Hypogonadism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Male Hypogonadism Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Male Hypogonadism Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Male Hypogonadism Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Male Hypogonadism Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Male Hypogonadism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Male Hypogonadism Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Male Hypogonadism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Male Hypogonadism Market Size by Country (2024-2033) & (US$ Million)
Table 46. Astrazeneca Plc. Company Detail
Table 47. Astrazeneca Plc. Business Overview
Table 48. Astrazeneca Plc. Male Hypogonadism Product
Table 49. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 50. Astrazeneca Plc. Recent Development
Table 51. Merck & Co. Inc. Company Detail
Table 52. Merck & Co. Inc. Business Overview
Table 53. Merck & Co. Inc. Male Hypogonadism Product
Table 54. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 55. Merck & Co. Inc. Recent Development
Table 56. Laboratories Genevrier Company Detail
Table 57. Laboratories Genevrier Business Overview
Table 58. Laboratories Genevrier Male Hypogonadism Product
Table 59. Laboratories Genevrier Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 60. Laboratories Genevrier Recent Development
Table 61. Allergan Plc. Company Detail
Table 62. Allergan Plc. Business Overview
Table 63. Allergan Plc. Male Hypogonadism Product
Table 64. Allergan Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 65. Allergan Plc. Recent Development
Table 66. Endo International Plc. Company Detail
Table 67. Endo International Plc. Business Overview
Table 68. Endo International Plc. Male Hypogonadism Product
Table 69. Endo International Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 70. Endo International Plc. Recent Development
Table 71. Ferring Company Detail
Table 72. Ferring Business Overview
Table 73. Ferring Male Hypogonadism Product
Table 74. Ferring Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 75. Ferring Recent Development
Table 76. AbbVie Inc. Company Detail
Table 77. AbbVie Inc. Business Overview
Table 78. AbbVie Inc. Male Hypogonadism Product
Table 79. AbbVie Inc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 80. AbbVie Inc. Recent Development
Table 81. Eli Lilly and Company Ltd. Company Detail
Table 82. Eli Lilly and Company Ltd. Business Overview
Table 83. Eli Lilly and Company Ltd. Male Hypogonadism Product
Table 84. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly and Company Ltd. Recent Development
Table 86. Finox Biotech Company Detail
Table 87. Finox Biotech Business Overview
Table 88. Finox Biotech Male Hypogonadism Product
Table 89. Finox Biotech Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 90. Finox Biotech Recent Development
Table 91. Teva Pharmaceutical Industries Ltd. Company Detail
Table 92. Teva Pharmaceutical Industries Ltd. Business Overview
Table 93. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product
Table 94. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Ltd. Recent Development
Table 96. Bayer AG Company Detail
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Male Hypogonadism Product
Table 99. Bayer AG Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. IBSA Institut Biochimque Company Detail
Table 102. IBSA Institut Biochimque Business Overview
Table 103. IBSA Institut Biochimque Male Hypogonadism Product
Table 104. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)
Table 105. IBSA Institut Biochimque Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Male Hypogonadism Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Male Hypogonadism Market Share by Type: 2022 VS 2033
Figure 3. Testosterone Replacement Therapy Features
Figure 4. Gonadotropin-Releasing Hormones Therapy Features
Figure 5. Global Male Hypogonadism Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Male Hypogonadism Market Share by Application: 2022 VS 2033
Figure 7. Kallmann Syndrome Case Studies
Figure 8. Klinefelters Syndrome Case Studies
Figure 9. Pituitary Disorders Case Studies
Figure 10. Others Case Studies
Figure 11. Male Hypogonadism Report Years Considered
Figure 12. Global Male Hypogonadism Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Male Hypogonadism Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Male Hypogonadism Market Share by Region: 2022 VS 2033
Figure 15. Global Male Hypogonadism Market Share by Players in 2022
Figure 16. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2022
Figure 18. North America Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Male Hypogonadism Market Share by Country (2018-2033)
Figure 20. United States Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Male Hypogonadism Market Share by Country (2018-2033)
Figure 24. Germany Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Male Hypogonadism Market Share by Region (2018-2033)
Figure 32. China Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Male Hypogonadism Market Share by Country (2018-2033)
Figure 40. Mexico Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Male Hypogonadism Market Share by Country (2018-2033)
Figure 44. Turkey Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Male Hypogonadism Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 47. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 48. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 49. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 50. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 51. Ferring Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 52. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 53. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 54. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 55. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 56. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 57. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed